Sargent Investment Group, LLC Amgen Inc Transaction History

Sargent Investment Group, LLC

$546 Million
Q3 2024

A detailed history of Sargent Investment Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sargent Investment Group, LLC holds 1,054 shares of AMGN stock, worth $278,772. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,054

Previous 1,044 0.96%

Holding current value

$278,772

Previous $326,000 3.99%

% of portfolio

0.06%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $3,093 - $3,373	10 Added 0.96%	1,054 $339,000
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $3,678 - $4,470	14 Added 1.36%	1,044 $326,000
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $4,301 - $5,192	16 Added 1.58%	1,030 $292,000
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $72,618 - $81,922	-284 Reduced 21.88%	1,014 $292,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $3,279 - $4,071	15 Added 1.17%	1,298 $348,000
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $642 - $760	3 Added 0.23%	1,283 $284,000
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $3,386 - $4,128	15 Added 1.19%	1,280 $309,000
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $68,709 - $87,303	300 Added 31.09%	1,265 $332,000
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $6,358 - $7,034	-29 Reduced 2.92%	965 $233,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $5,966 - $6,828	30 Added 3.11%	994 $224,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $11,887 - $13,927	-56 Reduced 5.49%	964 $205,000
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $39,708 - $44,053	170 Added 20.0%	1,020 $249,000
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $188,623 - $219,810	850 New	850 $211,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $183,923 - $219,019	-850 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $168,138 - $206,329	850 New	850 $217,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $154,904 - $205,445	-850 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$189.21 - $243.2 $160,828 - $206,720	850 New	850 $205,000
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $348,220 - $417,240	-2,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $356,800 - $416,500	2,000 New	2,000 $389,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Account

Sargent Investment Group, LLC Amgen Inc Transaction History